ShockWave Medical Stock (NASDAQ:SWAV)
Previous Close
$334.83
52W Range
$157.00 - $334.90
50D Avg
$325.08
200D Avg
$240.56
Market Cap
$12.57B
Avg Vol (3M)
$1.25M
Beta
0.88
Div Yield
-
SWAV Company Profile
ShockWave Medical, Inc., a medical device company, engages in developing and commercializing intravascular lithotripsy technology for the treatment of calcified plaque in patients with peripheral vascular, coronary vascular, and heart valve diseases worldwide. The company offers M5 catheters for treating above-the-knee peripheral artery disease (PAD); C2 catheters for treating coronary artery disease; and S4 catheters for treating below-the-knee PAD. It serves interventional cardiologists, vascular surgeons, and interventional radiologists through sales representatives and sales managers, and distributors. The company was incorporated in 2009 and is headquartered in Santa Clara, California.
SWAV Performance
Peer Comparison
| Ticker | Company |
|---|---|
| TMDX | TransMedics Group, Inc. |
| MASI | Masimo Corporation |
| PODD | Insulet Corporation |
| SYK | Stryker Corporation |
| EW | Edwards Lifesciences Corporation |
| CLPT | ClearPoint Neuro, Inc. |
| PEN | Penumbra, Inc. |
| DXCM | DexCom, Inc. |
| NARI | Inari Medical, Inc. |
| TNDM | Tandem Diabetes Care, Inc. |
| ALGN | Align Technology, Inc. |
| INSP | Inspire Medical Systems, Inc. |
| OM | Outset Medical, Inc. |